Fnu Avinashsingh Eswarsingh
Cardiovascular Disease · Jefferson City, TNNPI 1437637535
Payments from drug & device makers
Across 155 payments — averaging $58.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$3K
- AstraZeneca$855
- Amgen$717
- Abbott$569
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$557
- Johnson & Johnson$517
- plus $2K from 23 others
What the payments were for
- Travel & lodging$1,74719%
- Food & beverage$6,74175%
- Education$5306%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 32 | $3,338 |
| AstraZeneca(2 entities) | 19 | $855 |
| Amgen | 15 | $717 |
| Abbott | 4 | $569 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 18 | $557 |
| Johnson & Johnson | 9 | $517 |
| E.r. Squibb & Sons, L.L.C. | 5 | $354 |
| Boston Scientific | 2 | $317 |
| Medtronic | 7 | $290 |
| Novo Nordisk | 4 | $228 |
| Pfizer | 6 | $152 |
| Baxter Healthcare | 1 | $149 |
| Gilead | 4 | $139 |
| Boehringer Ingelheim | 9 | $135 |
| Abiomed | 1 | $135 |
| Sanofi | 1 | $125 |
| Biotronik Inc. | 3 | $101 |
| Angiodynamics, Inc. | 1 | $60 |
| Bayer | 2 | $40 |
| Shire North American Group Inc | 2 | $39 |
| Incyte Corporation | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| AbbVie | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$1,996
- ENSITE$530
- XARELTO$249
- CAMZYOS$245
- VersaCross Access Solution$219
- Hillrom - Cardiac Ambulatory Monitor$149
- SYMPLICITY G3$148
- Impella$135
- ANDEXXA$120
- FASENRA$104
How this compares
$9,018 in reported general payments places this provider in the 70th percentile of 429 cardiovascular disease providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $46,255 |
| EntrestoSacubitril/Valsartan | 22 | $29,097 |
| FarxigaDapagliflozin Propanediol | 34 | $20,275 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 65 | $916 |
| Ezetimibe | 50 | $859 |
| Metoprolol Succinate | 61 | $800 |
| Atorvastatin Calcium | 49 | $486 |
| Nebivolol Hcl | 14 | $381 |
| Nitroglycerin | 14 | $326 |
| Lisinopril | 45 | $319 |
| Amlodipine Besylate | 35 | $268 |
| Rosuvastatin Calcium | 17 | $222 |
| Metoprolol Tartrate | 40 | $196 |
| Bumetanide | 11 | $192 |
| Metformin Hcl | 14 | $165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $152 | $46,25542 claims |
| NovartisEntresto | $15 | $29,09722 claims |
| AstraZenecaFarxiga | $855 | $20,27534 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 429 cardiovascular disease providers in Tennessee.
Other cardiovascular disease in Jefferson City
- Brian LindmanNashville$5.5M
- David MetzgerKingsport$4.8M
- Christopher EllisNashville$4.1M
- Dinesh GuptaNashville$3.2M
- Joann LindenfeldNashville$2.2M
- Frank McGrewMemphis$2.1M
- Rebecca HungNashville$1.8M
- Mohsin AlhaddadJackson$1.8M
- Robert SmithBrentwood$1.3M
- Travis RichardsonNashville$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.